Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model

BACKGROUND: A recent recalibration of the ONCOTYROL Prostate Cancer Outcome and Policy (PCOP) Model, assuming that latent prostate cancer (PCa) detectable at autopsy might be detectable by screening as well, resulted in considerable worsening of the benefit-harm balance of screening. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mühlberger, Nikolai, Boskovic, Kristijan, Krahn, Murray D., Bremner, Karen E., Oberaigner, Willi, Klocker, Helmut, Horninger, Wolfgang, Sroczynski, Gaby, Siebert, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485506/
https://www.ncbi.nlm.nih.gov/pubmed/28651567
http://dx.doi.org/10.1186/s12889-017-4439-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485506/
https://www.ncbi.nlm.nih.gov/pubmed/28651567
http://dx.doi.org/10.1186/s12889-017-4439-9

Ejemplares similares